Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS).
Roncolato FT, O'Connell RL, Joly F, Lanceley A, Hilpert F, Buizen L, Okamoto A, Aotani E, Salutari V, Donnellan P, Oza A, Avall-Lundqvist E, Berek J, Fehm T, Ledermann J, Roemer-Becuwe C, Stockler MR, King MT, Friedlander ML. Roncolato FT, et al. Among authors: king mt. Gynecol Oncol. 2020 Jan;156(1):45-53. doi: 10.1016/j.ygyno.2019.10.001. Epub 2019 Dec 10. Gynecol Oncol. 2020. PMID: 31836184
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.
Friedlander M, Rau J, Lee CK, Meier W, Lesoin A, Kim JW, Poveda A, Buck M, Scambia G, Shimada M, Hilpert F, King MT, Debruyne P, Bologna A, Malander S, Monk BJ, Petru E, Calvert P, Herzog TJ, Barrett C, du Bois A. Friedlander M, et al. Among authors: king mt. Ann Oncol. 2018 Mar 1;29(3):737-743. doi: 10.1093/annonc/mdx796. Ann Oncol. 2018. PMID: 29267856 Free article. Clinical Trial.
Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy.
Musoro JZ, Sodergren SC, Coens C, Pochesci A, Terada M, King MT, Sprangers MAG, Groenvold M, Cocks K, Velikova G, Flechtner HH, Bottomley A; EORTC Quality of Life, Gastro-intestinal Groups. Musoro JZ, et al. Among authors: king mt. Colorectal Dis. 2020 Dec;22(12):2278-2287. doi: 10.1111/codi.15295. Epub 2020 Aug 28. Colorectal Dis. 2020. PMID: 32767619 Free article.
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Ediebah DE, Coens C, Zikos E, Quinten C, Ringash J, King MT, Schmucker von Koch J, Gotay C, Greimel E, Flechtner H, Weis J, Reeve BB, Smit EF, Taphoorn MJ, Bottomley A. Ediebah DE, et al. Among authors: king mt. Br J Cancer. 2014 May 13;110(10):2427-33. doi: 10.1038/bjc.2014.208. Epub 2014 Apr 17. Br J Cancer. 2014. PMID: 24743709 Free PMC article.
Coping with metastatic melanoma: the last year of life.
Brown JE, Brown RF, Miller RM, Dunn SM, King MT, Coates AS, Butow PN. Brown JE, et al. Among authors: king mt. Psychooncology. 2000 Jul-Aug;9(4):283-92. doi: 10.1002/1099-1611(200007/08)9:4<283::aid-pon460>3.0.co;2-n. Psychooncology. 2000. PMID: 10960926
329 results